Adverum Biotechnologies Q3 EPS $(0.33) Misses $(0.32) Estimate
Portfolio Pulse from Benzinga Newsdesk
Adverum Biotechnologies reported Q3 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.32) by 3.13 percent. However, this is a 17.5 percent increase over losses of $(0.40) per share from the same period last year.
November 09, 2023 | 10:26 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Adverum Biotechnologies' Q3 earnings per share missed estimates, but showed an improvement from last year.
Adverum Biotechnologies reported a larger loss than expected for Q3, which could negatively impact investor sentiment and the stock price. However, the year-over-year improvement might mitigate some of this negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100